Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Pra Health Sciences Inc's Business Segments
Pra Health Sciences Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2021
Reportable Segments
2
Largest Segment
Clinical Research
Total Revenue
$ 934
Regions Reported
2
Revenue Share by Reportable Segment - Q1 FY2021
- Clinical Research92.8%
- Data Solutions7.2%
Revenue by Reportable Segment - Q1 FY2021
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Clinical Research | $ 867 | 92.8% |
| Data Solutions | $ 67 | 7.2% |
Revenue Share by Region - Q1 FY2021
- Other Europe, Africa, and Asia-Pacific1.9%
- Other Americas0.7%
Revenue by Geographic Region - Q1 FY2021
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Other Europe, Africa, and Asia-Pacific | $ 17 | 1.9% |
| Other Americas | $ 7 | 0.7% |
Description of Pra Health Sciences Inc
PRA Health Sciences, Inc. is a multinational contract research organization (CRO) that provides innovative clinical research services to the biotechnology, pharmaceutical, and medical device industries. Founded in 1982 by Alan F. Hummel, the company has grown to become one of the world’s largest CROs.
PRA is headquartered in Raleigh, North Carolina, with more than 14,000 employees across 80 countries. The company has a strong global presence, with offices in North America, Europe, Asia Pacific, Latin America, and Africa.
The company’s services include clinical development services, early development services, and clinical trial management. These services include clinical research, data management, safety, regulatory affairs, medical writing, statistical analysis, and consultation services. PRA also provides customized solutions to meet the unique needs of its clients, whether that’s supporting a small biotech startup, a large pharmaceutical company or a medical device manufacturer.
PRA Health Sciences boasts an impressive track record of success in the industry, with a reputation for providing high-quality service and delivering client success. The company’s focus on innovation and technology has also allowed it to stay ahead of the competition, with proprietary technology platforms that streamline clinical trial operations.
PRA has been recognized with numerous accolades over the years, including being named one of the World’s Most Ethical Companies by Ethisphere Institute for five consecutive years and being ranked as one of the Top CROs by the 2019 Global Data CRO Market report.
Overall, PRA Health Sciences is a leading CRO that provides world-class clinical research services to the biotech, pharma, and medical device industries. With a global presence, innovative technology solutions, and a commitment to quality, PRA is well-positioned to continue its growth and success in the years to come.
PRA is headquartered in Raleigh, North Carolina, with more than 14,000 employees across 80 countries. The company has a strong global presence, with offices in North America, Europe, Asia Pacific, Latin America, and Africa.
The company’s services include clinical development services, early development services, and clinical trial management. These services include clinical research, data management, safety, regulatory affairs, medical writing, statistical analysis, and consultation services. PRA also provides customized solutions to meet the unique needs of its clients, whether that’s supporting a small biotech startup, a large pharmaceutical company or a medical device manufacturer.
PRA Health Sciences boasts an impressive track record of success in the industry, with a reputation for providing high-quality service and delivering client success. The company’s focus on innovation and technology has also allowed it to stay ahead of the competition, with proprietary technology platforms that streamline clinical trial operations.
PRA has been recognized with numerous accolades over the years, including being named one of the World’s Most Ethical Companies by Ethisphere Institute for five consecutive years and being ranked as one of the Top CROs by the 2019 Global Data CRO Market report.
Overall, PRA Health Sciences is a leading CRO that provides world-class clinical research services to the biotech, pharma, and medical device industries. With a global presence, innovative technology solutions, and a commitment to quality, PRA is well-positioned to continue its growth and success in the years to come.
PRA Health Sciences Inc. is recognized as one of the leading Contract Research Organizations (CROs) globally, specializing in a wide array of segments, products, and services that cater to the demands of pharmaceutical and biotechnology companies throughout the drug development lifecycle.
Segments
1. Clinical Development:
- Clinical Trial Management: PRA oversees the design, implementation, and execution of clinical trials, ensuring compliance with regulatory requirements and therapeutic protocols.
- Site Management: This entails the selection and management of clinical trial sites, along with staff training and logistical support to ensure optimal performance.
- Monitoring: PRA employs clinical research associates (CRAs) who monitor clinical sites for compliance with Good Clinical Practice (GCP) and overall trial integrity.
- Patient Recruitment: Specialized teams focus on targeted recruitment strategies to ensure diverse and adequate patient populations for trials.
- Safety Monitoring: Ongoing assessment of patient safety through adverse event tracking and reporting, utilizing robust pharmacovigilance practices.
2. Strategic Solutions:
- Drug Development Consulting: Providing comprehensive advice across all phases of drug development to align with regulatory requirements and market needs.
- Regulatory Consulting: Assistance with regulatory submissions, including IND applications and responses to regulatory inquiries to facilitate smooth interactions with regulatory bodies.
- Pharmacovigilance: Monitoring the safety of pharmaceutical products throughout their lifecycle to ensure ongoing compliance with safety regulations and risk management plans.
- Medical Writing: Creation of essential documentation including clinical study reports, regulatory submissions, and scientific publications, ensuring clarity and adherence to industry standards.
3. Early Development:
- Non-Clinical Safety Assessment: Conducting toxicology studies to evaluate the safety profile of drug candidates before they enter clinical trials.
- Clinical Pharmacology: Design and execution of clinical pharmacology studies to assess drug absorption, distribution, metabolism, elimination, and effects in humans.
- Bioanalytical Services: Offering analytical services for assessing drug levels in biological samples, providing crucial pharmacokinetic data.
- Bioequivalence Studies: Conducting studies to establish the equivalence of generic drugs to their branded counterparts.
Products
1. PRAes EDC (Electronic Data Capture) Systems:
- A state-of-the-art EDC platform that replaces traditional paper-based systems with an efficient, user-friendly electronic solution. This platform enhances data collection accuracy, facilitates real-time monitoring, and streamlines data management processes.
2. PRAes Technologies:
- A comprehensive suite of integrated technology solutions designed to enhance clinical trial efficiency:
- Clinical Trial Management Systems (CTMS): Tools that manage trial processes, resource allocation, and data storage effectively.
- Interactive Response Technology (IRT): Streamlining randomization and drug supply management to ensure timely and accurate distribution of study drugs.
- Electronic Patient-Reported Outcomes (ePRO): Digital solutions empowering patients to report on their health status directly, improving data quality and patient engagement.
Services
1. Clinical Research:
- Providing end-to-end clinical research services, from the initiation phase through to the closure of clinical trials. This encompasses protocol development, study execution, site monitoring, and final reporting.
2. Data and Analytics:
- Delivering comprehensive data analysis services tailored to the unique needs of clients, utilizing advanced statistical methodologies to extract insights from complex datasets. This includes data visualization and management to support decision-making processes.
3. Post-Approval Services:
- A robust offering of services designed to support pharmaceuticals and biotechnology companies post-product approval, including:
- Pharmacovigilance: Ongoing monitoring and reporting of drug safety data.
- Medical Affairs: Strategic communications and scientific engagement with healthcare professionals to ensure successful product incorporation into treatment paradigms.
- Regulatory Services: Continuous compliance support as products transition from development into the marketplace.
4. Real World Solutions:
- PRA leverages real-world evidence to provide actionable insights, which include:
- Observational Studies: Research analyzing the use and effectiveness of treatments in real-world settings.
- Patient Registries: Establishing registries to track patient outcomes and treatment patterns in specific populations.
- Health Economics Research: Analyzing economic aspects of healthcare interventions to support market access and value propositions.
Conclusion
PRA Health Sciences Inc. stands out as a comprehensive, full-service CRO, offering an extensive range of segments, products, and services. They aim to partner closely with pharmaceutical and biotechnology firms, leveraging their deep expertise and innovative technologies to accelerate the development and success of new therapeutic interventions in the marketplace.
Segments
1. Clinical Development:
- Clinical Trial Management: PRA oversees the design, implementation, and execution of clinical trials, ensuring compliance with regulatory requirements and therapeutic protocols.
- Site Management: This entails the selection and management of clinical trial sites, along with staff training and logistical support to ensure optimal performance.
- Monitoring: PRA employs clinical research associates (CRAs) who monitor clinical sites for compliance with Good Clinical Practice (GCP) and overall trial integrity.
- Patient Recruitment: Specialized teams focus on targeted recruitment strategies to ensure diverse and adequate patient populations for trials.
- Safety Monitoring: Ongoing assessment of patient safety through adverse event tracking and reporting, utilizing robust pharmacovigilance practices.
2. Strategic Solutions:
- Drug Development Consulting: Providing comprehensive advice across all phases of drug development to align with regulatory requirements and market needs.
- Regulatory Consulting: Assistance with regulatory submissions, including IND applications and responses to regulatory inquiries to facilitate smooth interactions with regulatory bodies.
- Pharmacovigilance: Monitoring the safety of pharmaceutical products throughout their lifecycle to ensure ongoing compliance with safety regulations and risk management plans.
- Medical Writing: Creation of essential documentation including clinical study reports, regulatory submissions, and scientific publications, ensuring clarity and adherence to industry standards.
3. Early Development:
- Non-Clinical Safety Assessment: Conducting toxicology studies to evaluate the safety profile of drug candidates before they enter clinical trials.
- Clinical Pharmacology: Design and execution of clinical pharmacology studies to assess drug absorption, distribution, metabolism, elimination, and effects in humans.
- Bioanalytical Services: Offering analytical services for assessing drug levels in biological samples, providing crucial pharmacokinetic data.
- Bioequivalence Studies: Conducting studies to establish the equivalence of generic drugs to their branded counterparts.
Products
1. PRAes EDC (Electronic Data Capture) Systems:
- A state-of-the-art EDC platform that replaces traditional paper-based systems with an efficient, user-friendly electronic solution. This platform enhances data collection accuracy, facilitates real-time monitoring, and streamlines data management processes.
2. PRAes Technologies:
- A comprehensive suite of integrated technology solutions designed to enhance clinical trial efficiency:
- Clinical Trial Management Systems (CTMS): Tools that manage trial processes, resource allocation, and data storage effectively.
- Interactive Response Technology (IRT): Streamlining randomization and drug supply management to ensure timely and accurate distribution of study drugs.
- Electronic Patient-Reported Outcomes (ePRO): Digital solutions empowering patients to report on their health status directly, improving data quality and patient engagement.
Services
1. Clinical Research:
- Providing end-to-end clinical research services, from the initiation phase through to the closure of clinical trials. This encompasses protocol development, study execution, site monitoring, and final reporting.
2. Data and Analytics:
- Delivering comprehensive data analysis services tailored to the unique needs of clients, utilizing advanced statistical methodologies to extract insights from complex datasets. This includes data visualization and management to support decision-making processes.
3. Post-Approval Services:
- A robust offering of services designed to support pharmaceuticals and biotechnology companies post-product approval, including:
- Pharmacovigilance: Ongoing monitoring and reporting of drug safety data.
- Medical Affairs: Strategic communications and scientific engagement with healthcare professionals to ensure successful product incorporation into treatment paradigms.
- Regulatory Services: Continuous compliance support as products transition from development into the marketplace.
4. Real World Solutions:
- PRA leverages real-world evidence to provide actionable insights, which include:
- Observational Studies: Research analyzing the use and effectiveness of treatments in real-world settings.
- Patient Registries: Establishing registries to track patient outcomes and treatment patterns in specific populations.
- Health Economics Research: Analyzing economic aspects of healthcare interventions to support market access and value propositions.
Conclusion
PRA Health Sciences Inc. stands out as a comprehensive, full-service CRO, offering an extensive range of segments, products, and services. They aim to partner closely with pharmaceutical and biotechnology firms, leveraging their deep expertise and innovative technologies to accelerate the development and success of new therapeutic interventions in the marketplace.